Advertisements



Heron Therapeutics (HRTX) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsDec 7th, 2017

United Therapeutics (UTHR) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsNov 29th, 2017

Ultragenyx Seeks An FDA Win For Biologic Therapy Candidate

After Heron Therapeutics Inc (NASDAQ: HRTX), Bristol-Myers Squibb Co (NYSE: BMY) and Dynavax Technologies Corporation (NASDAQ: DVAX) read more.....»»

Category: blogSource: benzingaNov 15th, 2017

Heron Therapeutics (HRTX) Announces U.S. FDA Approval of CINVANTI(TM) - Slideshow

Heron Therapeutics (HRTX) Announces U.S. FDA Approval of CINVANTI(TM) - Slideshow.....»»

Category: topSource: seekingalphaNov 12th, 2017

Private Asset Management Inc Buys DowDuPont Inc, Heron Therapeutics Inc, CME Group Inc, Sells ...

Related Stocks: FMBL, DWDP, HRTX, CME, BMRN, NVIV, QCOM, GE, BAC, CVX, JPM, P,.....»»

Category: personnelSource: nytOct 3rd, 2017

Should You Buy Heron Therapeutics (HRTX) Ahead of Earnings

Heron Therapeutics (HRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP ahead of earnings. Investors are always looking for stocks that are poised to beat.....»»

Category: topSource: zacksAug 10th, 2017

Cara Therapeutics (CARA) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsAug 5th, 2017

Sarepta Therapeutics (SRPT) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsJun 21st, 2017

Rubric Capital Management LP Buys Xperi, Braskem SA, Heron Therapeutics, Sells Olin, Signet ...

Related Stocks: BAK, HRTX, KRA, CNDT, GMS, MDCA, XPER, GPK, BYD, HRI, SNCR, R,.....»»

Category: personnelSource: nytApr 28th, 2017

Acorda Therapeutics (ACOR) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsMar 31st, 2017

Heron Therapeutics (HRTX) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow

Heron Therapeutics (HRTX) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow.....»»

Category: topSource: seekingalphaMar 22nd, 2017

Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN

In new guidelines, Heron Therapeutics Inc (NASDAQ:HRTX) has announced that Sustol will be included as an extended-release injection. A rec.....»»

Category: topSource: insidermonkeyMar 1st, 2017

Insys Therapeutics Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsFeb 22nd, 2017

Heron Therapeutics Inc (NASDAQ:HRTX) Heffx Technical Analysis

Heron Therapeutics Inc (NASDAQ:HRTX) Heffx Technical Analysis Overall, the bias in prices is: Downwards. Short term: Prices are moving. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to the.....»»

Category: topSource: livetradingnewsJan 9th, 2017

Heron Therapeutics Inc (NASDAQ:HRTX) Bearish Long Term Projection

Heron Therapeutics Inc (NASDAQ:HRTX) Bearish Long Term Projection Overall, the bias in prices is: Downwards. Short term: Prices are stalling. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to t.....»»

Category: topSource: livetradingnewsJan 4th, 2017

Heron Therapeutics (NASDAQ:HRTX) Heffx Technical Analysis with Candlesticks

Heron Therapeutics (NASDAQ:HRTX) Heffx Technical Analysis with Candlesticks Overall, the bias in prices is: Downwards. Short term: Prices are moving. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to the downsid.....»»

Category: topSource: livetradingnewsDec 30th, 2016

Sarepta Therapeutics (SRPT) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsDec 22nd, 2016

Is Heron Therapeutics Inc (HRTX) a Good Stock To Buy?

The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of course, most hedge funds and other asset managers have been underperforming main stock market indices sin.....»»

Category: topSource: insidermonkeyDec 12th, 2016

Amicus Therapeutics: Here"s The Good News

Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) plunged more than 22 percent on news that the FDA seeks a pivotal "cross-over" study of Galafold (migalastat) in treatment-naive Fabry disease patients with gastrointestinal (GI) symptoms to approve La.....»»

Category: blogSource: benzingaNov 29th, 2016

Noteworthy Monday Option Activity: HRTX, GOOGL, CIEN

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Heron Therapeutics Inc (NASD: HRTX), where a total volume of 8,440 contracts has been traded thus far today, a contract volume which is r.....»»

Category: optionsSource: forbesNov 28th, 2016

Anika Therapeutics (ANIK) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsNov 23rd, 2016